P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB
N. Marschner,
J. Hanselmann,
S. McGough,
S. Braun,
S. Pfizler-Dempfle,
R. Sandner,
J. Mohm,
M. Jaber,
D. Hamm,
N. Hamm,
M. Jaenicke,
A. Shewade
Affiliations
N. Marschner
1 Outpatient Centre for Interdisciplinary Oncology and Haematology
J. Hanselmann
2 Biostatistics, iOMEDICO, Freiburg, Germany
S. McGough
3 Roche Global Product Development Data Sciences, Genentech, Inc., South San Francisco, CA, United States of America
S. Braun
4 Biometrics and Epidemiology. Roche Pharma AG, Grenzach-Wyhlen
S. Pfizler-Dempfle
5 Oncology and Haematology Outpatient Centre, Kaiserslautern
R. Sandner
6 MVZ for Haematology and Oncology, Passau
J. Mohm
7 Oncology and Haematology Outpatient Centre, Dresden, Germany
M. Jaber
8 Roche Global Access, F. Hoffmann-La Roche Ltd, Basel, Switzerland
D. Hamm
9 Medical Affairs Excellence, Roche Pharma AG, Grenzach-Wyhlen
